P&G/Gillette merger
This article was originally published in The Tan Sheet
Executive Summary
Massachusetts Secretary of the Commonwealth William Galvin subpoenas Goldman Sachs Chairman and CEO Henry Paulson to testify June 23 regarding fairness opinions by the company relating to the acquisition of Gillette by Procter & Gamble. Galvin also subpoenas Bank of America Secretary and Deputy Counsel William Mostyn, a former Gillette employee, and UBS Securities' Eric Derheimer to testify June 21 and June 27, respectively. The subpoenas, issued June 13, are the most recent in Galvin's ongoing investigation of the merger (1"The Tan Sheet" Feb. 21, 2005, p. 11)...
You may also be interested in...
Massachusetts Expands Gillette Sale Probe To Employee Retirement Benefits
Massachusetts Secretary of the Commonwealth William Galvin is widening his investigation into Procter & Gamble's proposed acquisition of Gillette, citing retire-ment benefits for Gillette employees among his concerns
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.